Asia
Samsung Galaxy Note 7 Iris Scanner Explained: Why New Mobile Security Feature Is Considered A Game Changer
For the past two days, Samsung has been talking about its Galaxy Note 7's iris scanner on its online newsroom, highlighting the reasons why this new mobile security feature could be a big game changer in the mobile industry. Just yesterday, the South Korean-headquartered company discussed how the iris scanning technology is making Samsung Pass even more secure. Samsung Pass is part of Knox, the comprehensive security platform of Samsung's recent handsets. Pass previously centered on fingerprint recognition via the fingerprint scanner as a means of enhancing the identity verification process of the phone itself and certain apps. With the addition of the iris scanner, Samsung claims that the Note 7's security has reached the ultimate level thanks to this advanced biometric authentication that does not require IDs or passwords for identity authentication.
The future of AI search could revolutionize the way you go out for pizza
Start-ups are hoping new artificial intelligence (AI) techniques that make searching the web more like talking to a friend will help them take on Google. Companies are developing search software that understands natural language, something that has typically been difficult for computers to do. Israel-based start-up Twiggle has come up with a solution specifically for e-commerce. The company, backed by Chinese online shopping giant Alibaba, is trying to help make searching sites for items a lot easier. "We are trying to bring the search experience as close as possible to the positive aspect of the in-store experience," Amir Konigsberg, chief executive of Twiggle, told CNBC in a phone interview on Wednesday.
China to use artificial intelligence for Next-Gen missiles
Except where specifically authorised, the reader may not modify, copy, reproduce, republish, upload, post, transmit or distribute in any way any material from this site including code and software. The Company shall have the right at any time to change or modify the terms and conditions applicable to user's use of the ianslive.in By visiting our site you are agreeing to be bound by the following terms and conditions. We may change these terms and conditions at any time. The term'ianslive.in' is used through this entire Terms of Use document to refer to the website, its owners and the employees and associates of the owner You may not resell, redistribute, broadcast or transfer information, software and applications or use the information, software and applications provided by ianslive.in in a searchable, machine-readable database unless separately and specifically authorized in writing by ianslive.in
Dyson's 360 Eye robot vacuum succeeds by seeing more
Dyson's 360 Eye robot vacuum has been a long time coming to U.S. carpets. The squat little cylinder of a bot first broke cover in September 2014, with a splashy product announcement and a consumer launch in Japan in 2015. North American homes are only just getting their first taste of Dyson's inaugural foray into robotics, however, and my own has been playing host to one for the past couple of weeks. The Dyson 360 Eye is unsurprisingly a terrific vacuum, but it does have room for improvement for a robot – which isn't saying anything new for the category. The bottom line is that Dyson's robot already delivers a better, more reliable clean than the Roomba 595 Pet Vacuum robot I was using previously, and thanks to a commitment by Dyson to continuous improvement, should only get even better over time.
Artificial intelligence could transform healthcare, but we need to accept it first
Scientists in Japan reportedly saved a woman's life by applying artificial intelligence to help them diagnose a rare form of cancer. Faced with a 60-year-old woman whose cancer diagnosis was unresponsive to treatment, they supplied an AI system with huge amounts of clinical cancer case data, and it diagnosed the rare leukemia that had stumped the clinicians in just ten minutes. The Watson AI system from IBM matched the patient's symptoms against 20m clinical oncology studies uploaded by a team headed by Arinobu Tojo at the University of Tokyo's Institute of Medical Science that included symptoms, treatment and response. The Memorial Sloan Kettering Cancer Center in New York has carried out similar work, where teams of clinicians and data analysts trained Watson's machine learning capabilities with oncological data in order to focus its predictive and analytic capabilities on diagnosing cancers. IBM Watson first became famous when it won the US television game show Jeopardy in 2011.